Cargando…
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
OBJECTIVE: To investigate the safety and effectiveness of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) after recent stroke in patients with atrial fibrillation (AF) aged ≥85 years. METHODS: Individual patient data analysis from seven prospective stroke cohorts. We compared DO...
Ejemplares similares
-
Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation
por: Kubacka, Marta, et al.
Publicado: (2023) -
Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022) -
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
por: Schaub, Fabian, et al.
Publicado: (2021) -
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
por: Seiffge, David J., et al.
Publicado: (2019) -
Cerebral Amyloid Angiopathy and the Risk of Hematoma Expansion
por: Seiffge, David J., et al.
Publicado: (2022)